Inventor
WALLACE MICHAEL BRENNAN
US63 patents
⚠️ This page may combine multiple inventors who share the name “WALLACE MICHAEL BRENNAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE QUANTICEL RES INC
33 patentsUS10202381B2Feb 12, 2019
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC4 citations84
US10112940B2Oct 30, 2018
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC4 citations84
US10059687B2Aug 28, 2018
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC4 citations84
US9815828B2Nov 14, 2017
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC4 citations84
US9725441B2Aug 8, 2017
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC2 citations84
US9586902B2Mar 7, 2017
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC5 citations84
US11890275B2Feb 6, 2024
Therapeutic compounds
CELGENE QUANTICEL RES INC1 citations73
US11535616B2Dec 27, 2022
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC2 citations73
US11214542B2Jan 4, 2022
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations73
US11020380B2Jun 1, 2021
Therapeutic compounds
CELGENE QUANTICEL RES INC2 citations73
US11001568B2May 11, 2021
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations73
US10870634B2Dec 22, 2020
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations73
US10815234B2Oct 27, 2020
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC2 citations73
US10807956B2Oct 20, 2020
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations73
US10654830B2May 19, 2020
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations73
US10617680B2Apr 14, 2020
Therapeutic compounds
CELGENE QUANTICEL RES INC3 citations73
US10611763B2Apr 7, 2020
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC2 citations73
US10597365B2Mar 24, 2020
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations73
US10597379B2Mar 24, 2020
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations73
US10385047B2Aug 20, 2019
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations73
US10208039B2Feb 19, 2019
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC4 citations73
US10179769B2Jan 15, 2019
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations73
US10030017B2Jul 24, 2018
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC4 citations73
US9873697B2Jan 23, 2018
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC3 citations73
US12172998B2Dec 24, 2024
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC0 citations63
US11884648B2Jan 30, 2024
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC0 citations63
US11731954B2Aug 22, 2023
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC0 citations63
US10150754B2Dec 11, 2018
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations63
US10106534B2Oct 23, 2018
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations63
US9994561B2Jun 12, 2018
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations63
US9828343B2Nov 28, 2017
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations63
US9611221B2Apr 4, 2017
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations63
US10202360B2Feb 12, 2019
Therapeutic compounds
CELGENE QUANTICEL RES INC1 citations62
QUANTICEL PHARMACEUTICALS INC
11 patentsUS8952151B2Feb 10, 2015
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC21 citations96
US9447045B2Sep 20, 2016
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC20 citations93
US9242968B2Jan 26, 2016
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC17 citations93
US9085534B2Jul 21, 2015
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC8 citations93
US9643965B2May 9, 2017
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC6 citations84
US9447046B2Sep 20, 2016
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC4 citations84
US9107916B2Aug 18, 2015
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC4 citations84
US9758517B2Sep 12, 2017
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC2 citations73
US9738637B2Aug 22, 2017
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC3 citations73
US11639333B2May 2, 2023
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC0 citations63
US9458129B2Oct 4, 2016
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC1 citations63
AGOURON PHARMA
6 patentsUS6884890B2Apr 26, 2005
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
AGOURON PHARMA178 citations98
US6534524B1Mar 18, 2003
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
AGOURON PHARMA277 citations98
US7232912B2Jun 19, 2007
Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
AGOURON PHARMA94 citations96
US7141587B2Nov 28, 2006
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
AGOURON PHARMA17 citations92
US6891044B2May 10, 2005
Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their use
AGOURON PHARMA20 citations92
US6369226B1Apr 9, 2002
Substituted benzamide inhibitors of rhinovirus 3C protease
AGOURON PHARMA5 citations62
Showing the top 50 of 63 patents by PatentIndex Score.